Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Gastrointest Endosc. 2017 Apr 25;87(1):88–94.e2. doi: 10.1016/j.gie.2017.04.019

Table 5.

Two-way comparisons of total costs between sEGD, huTNE and muTNE groups.

Pairwise comparison (first modality vs second modality) Mean costs in U.S.$ (95% CI) of first modality Mean costs in U.S.$ (95% CI) of second modality Difference in mean costs in U.S. $ (95% CI)
sEGD vs muTNE $2,187.67 ($2,110.40 to $2,217.72) $490.70 ($481.89 to $506.44) $1,617.02 ($1,615.83 to $1,727.14)
sEGD vs huTNE $2,273.23 ($2,215.19 to $2,393.15) $928.93 ($883.69 to $954.98) $1,386.72 ($1,291.79 to $1,486.07)
muTNE vs huTNE $512.31 ($488.61 to $533.72) $944.34 ($905.64 to $983.51) −$432.66 (−$479.47 to −$390.26)

Predicted mean total costs, incremental mean differences and 95% confidence intervals of two-way analyses.